T-cell lymphoma: Difference between revisions
Jump to navigation
Jump to search
m (Robot: Automated text replacement (-{{SIB}} +, -{{EH}} +, -{{EJ}} +, -{{Editor Help}} +, -{{Editor Join}} +)) |
|||
Line 17: | Line 17: | ||
{{CMG}} | {{CMG}} | ||
{{T cell lymphoma}} | {{T cell lymphoma}} | ||
==[[T-cell lymphoma overview|Overview]]== | ==[[T-cell lymphoma overview|Overview]]== | ||
Line 47: | Line 47: | ||
{{Hematological malignancy histology}} | {{Hematological malignancy histology}} | ||
[[Category:Hematology]] | [[Category:Hematology]] | ||
[[Category:Types of cancer]] | [[Category:Types of cancer]] |
Revision as of 16:29, 20 August 2012
For patient information click here.
T-cell lymphoma | |
MeSH | D016399 |
---|
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
Historical Perspective
Pathophysiology
Epidemiology & Demographics
Risk Factors
Screening
Causes
Differentiating T-cell lymphoma
Complications & Prognosis
Diagnosis
History and Symptoms | Physical Examination | Staging | Laboratory tests | Electrocardiogram | X Rays | CT | MRI Echocardiography or Ultrasound | Other images | Alternative diagnostics
Treatment
Medical therapy | Surgical options | Primary prevention | Secondary prevention | Financial costs | Future therapies
See also